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The human immunodeficiency virus type 1 (HIV-1) genes vpu, env, and nef have all been implicated in
modulating the levels of cell surface CD4 on infected cells. To quantitatively assess the relative contribution
of each gene product to the regulation of CD4 during HIV infection of Jurkat T cells and peripheral blood
mononuclear cells, we have developed an infectious HIV reporter system which expresses different combina-
tions of these genes. To distinguish infected cells in the early or late stages of infection from uninfected cells,
these viruses were designed to express human placental alkaline phosphatase with the kinetics of either early
or late viral genes. Flow cytometry to detect placental alkaline phosphatase and CD4 in infected cells showed
that vpu, env, and nef are independently capable of down-modulation of CD4. As predicted by their respective
expression patterns, nef down-modulated CD4 rapidly during the early phase of virus infection whereas vpu and
env functioned late in the infection. In both Jurkat cells and peripheral blood mononuclear cells, a combination
of the three genes was more efficient than any one or two genes, demonstrating that all three genes are required
to achieve maximal CD4 down-modulation. In primary cells, down-modulation of CD4 was less efficient than
in Jurkat cells and there was a stronger dependence on nef function for reducing cell surface CD4. HIV
therefore has three genes that are able to independently down-modulate CD4; together, they can eliminate the
bulk of cell surface CD4.
The CD4 molecule plays a central role in the pathogenesis of
AIDS (reviewed by Bour et al. [4]). Depletion of the T cells
which carry this marker is the clinical hallmark of the immune
system dysfunction characteristic of AIDS. In humans infected
with human immunodeficiency virus (HIV), the CD4 cell sur-
face antigen serves as the major receptor for the virus (17, 23).
CD4 is also of pivotal importance in the development and
maintenance of normal immune function. The binding of CD4
to major histocompatibility complex type II on antigen-pre-
senting cells plays an essential role in the process of T-cell
antigen recognition and subsequent T-cell activation (reviewed
by Weiss and Littman [39]).
Early studies of HIV infection in vitro suggested that infec-
tion of cells could down-modulate cell surface CD4 (9, 17).
Since then, numerous experiments based largely upon stable or
transient transfection have implicated the actions of the viral
genes env, vpu, and nef in this process. These genes appear to
work through different mechanisms; however, the independent
activities or potential cooperativity of their gene products dur-
ing HIV infection of human T cells has not been investigated.
env and vpu are coordinately expressed on a dicistronic,
singly spliced mRNA (32). Because efficient expression is de-
pendent upon prior expression of the early viral protein, Rev,
vpu and env are referred to as late genes. The env gene product
is a glycoprotein, gp160, which mediates virus binding and
fusion to the host cell. Stable expression of env in CD41 cells
can down-modulate CD4 (35). Analysis of stable cell lines
expressing gp160 shows that it can bind to CD4 in the endo-
plasmic reticulum to form aggregates that are retained in the
endoplasmic reticulum (8, 15).
Vpu is a viral integral membrane phosphoprotein that was
originally characterized as a 16-kDa protein which increases
viral particle release from infected cells (36). Subsequent stud-
ies demonstrated that expression of Vpu could decrease the
half-life of CD4 in experiments on transfected HeLa epithelial
carcinoma cells (40). In this system, the effect of vpu on the
stability of CD4 was dependent upon the presence of coex-
pressed gp160 capable of interaction with CD4. Although the
mechanism of the effect of vpu on CD4 is still unclear, recent
studies have demonstrated direct in vitro binding of vpu to the
cytoplasmic tail of CD4 (5).
The HIV regulatory protein Nef is a myristylated 27-kDa
protein expressed early during virus infection from a multiply
spliced transcript (16, 18). Nef can also down-modulate CD4 as
one of its functions (10, 12). Expression of nef in a T-cell line
appears to induce cell surface CD4 endocytosis which is de-
pendent upon a dileucine motif in the cytoplasmic tail of CD4
(1). A second function of nef is to increase viral replication
rates (25, 34); however, this activity and its ability to down-
modulate CD4 can be separated by specific point mutations in
nef (29). The mechanisms by which nef affects cell surface CD4
levels and viral replication rates remain unclear.
Many reports concerning the mechanisms of CD4 modula-
tion by each of these viral gene products have appeared; how-
ever, none has provided a quantitative picture of the efficiency
of action of each during infection of CD41 T cells. It is unclear
whether each gene can function independently and to what
extent CD4 is removed from the cell surface during infection.
Furthermore, no data exist regarding the potential cooperat-
ivity with which these genes act during infection of T-cell lines
or primary human T cells by HIV. In this study, we systemat-
ically demonstrate the individual and combinatorial effects of
vpu, env, and nef on cell surface CD4 during infection of hu-* Corresponding author.
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man T cells. To assess the changes in cell surface CD4 during
the different stages of virus infection, we have developed an
infectious HIV reporter system which permits quantitative ex-
amination of infected cells at various stages of infection via
flow cytometry. Using such a system, we find that a virus lack-
ing nef, vpu, and env does not down-modulate CD4. Each of
these three genes is then able to independently down-modulate
CD4. These effects are present with a greater efficiency in
Jurkat cells than in primary human T cells. Together, these
three viral genes are able to eliminate the preponderance of
surface CD4 from infected cells.
MATERIALS AND METHODS
Cells. Jurkat clone E6-1 was obtained from the AIDS Reagent Repository,
donated by Arthur Weiss. Peripheral blood mononuclear cells (PBMC) were
isolated from HIV- and hepatitis B virus-seronegative donors. PBMC from buffy
coats were purified by centrifugation over a Ficoll-Hypaque (Pharmacia) gradi-
ent and incubated overnight in RPMI 1640 containing 2 mg of phytohemagglu-
tinin (PHA) per ml and 10% fetal calf serum. Subsequently, PBMC were main-
tained in RPMI–10% fetal calf serum with 20 U of recombinant interleukin-2
(Genzyme) per ml.
Viruses. HIV proviral constructs are based upon R7, a modified clone of
HXB-2D which contains a repaired nef open reading frame (kindly provided by
Mark Feinberg). Virus was produced by calcium phosphate transfection of 293
cells by standard methods (27). Virus from the transfection was quantitated by
p24 enzyme-linked immunosorbent assay prior to infection (26). Infections were
performed for 8 to 12 h in 8 mg of Polybrene per ml. Viral constructs were
produced with standard recombinant DNA methods as described below.
To create the virus designated HXBnPLAP, we inserted a placental alkaline
phosphatase (PLAP) gene amplified by PCR in the nef site, replacing the lucif-
erase gene in HXB-Luc (7). The PLAP gene was amplified with the primers
59-ACT CAC AGA GCG GCC GCA CTG CTG CTG CTG CTG CTG CTG
GGC-39 and 59-CGC TAT ACG CGT CTC GAG TCA GGG AGC AGT GGC
CGT CTC-39, Pfu polymerase (Stratagene), and 100 ng of template PLAP
cDNA, using 20 amplification cycles (948C for 30 s, 558C for 30 s, and 728C for
3 min) under buffer conditions recommended by the manufacturer. To repair the
translation initiation codon of vpu, which is defective in HXB-2D, PCR-mediated
mutagenesis was used to generate a BamHI-SalI fragment isogenic with the
normal HXB-2D sequence except for the creation of an ACG-to-ATG point
mutation at the initiation codon of vpu. Constructs were confirmed along the
entire PCR-amplified region by sequence analysis (ABI Sequenator; Applied
Biosystems). A frameshift in the env reading frame was introduced by partial
digestion with NdeI and filling in with the Klenow fragment of DNA polymerase.
To insert the internal ribosomal entry site (IRES) element of encephalomyocar-
ditis virus at the 59 end of the nef reading frame and to reintroduce the 59 end of
nef, a PCR-mediated method was used. Briefly, a PCR fragment of the IRES
element was generated with the primers 59-GGT ACG TAC GTC GAC GAA
TTC CGC CCC TCT CCC TCC-39 and 59-ACT TTT TGA CCA CTT GCC
ACC CAT ATT ATC ATC GTG TTT TTC AAA-39. The resulting fragment
produces a fusion gene with the IRES sequence immediately followed by 24
nucleotides of the 59 end of nef. A second PCR fragment of the 59 end of nef
extending past the unique XhoI site was also generated. A fusion PCR product
was generated with these two PCR products as a template in a third PCR
reaction. The resulting fragment was cloned into pBluescript, and its sequence
was confirmed before transfer into the unique XhoI site in HXBnPLAP.
To insert PLAP into the 59 end of the env gene, a polylinker was first inserted
to replace the 59 end of the env gene, deleting the initial 1,035 nucleotides of env
coding sequence up to an NheI site. A PLAP gene was inserted into the resulting
virus to create HXBePLAP. To create HXBePLAP N2, a frameshift mutation
was introduced into the nef open reading frame by cutting with XhoI, filling in
with Klenow, and religating the blunt-ended fragment.
Murine leukemia virus (MLV) vector expressing PLAP, DAP, was a gift from
Connie Cepko (6). Helper-free amphotropic retrovirus was produced by tran-
sient transfection of the amphotropic MLV-packaging cell line, BING, as pre-
viously described (27).
Flow cytometry and Western blot analysis. Cells were stained with a 1:400
dilution of rabbit anti-human PLAP (DAKO) and a 1:100 dilution of anti-human
CD4-biotin (Caltag). Goat anti-rabbit fluorescein isothiocyanate, human and
mouse serum adsorbed (BioSource International) at 1:250, and streptavidin PE
(Caltag) at 1:250 were used as secondary stains. Samples were fixed in 1%
paraformaldehyde prior to analysis. Flow cytometry was performed on a FAC-
SCAN (Becton Dickinson) with CellQuest (Becton Dickinson) data acquisition
and analysis software. The data shown are gated on living cells on the basis of
forward-scatter and side-scatter characteristics. Fluorescence compensation was
adjusted on control samples labeled with single fluorochromes to minimize the
effects of spectral overlap. The following antibodies for Western blotting (im-
munoblotting) of Vpu, Env, Nef, and HIV proteins were obtained from the
AIDS Research and Reference Reagent Program, Division of AIDS, National
Institute of Allergy and Infectious Diseases: anti-HIV-1 Vpu rabbit serum from
Frank Maldarelli and Klaus Strebel, anti-Env sheep serum from Michael Phelan,
anti-HIV-1 Nef rabbit serum from BioTechnology General, and pooled human
HIV immune globulin from Alfred Prince.
RESULTS
PLAP reporter system. We engineered an infectious HIV
strain to express a cell surface marker that could be monitored
by flow cytometry by introducing the human PLAP gene (13)
into the molecular clone of HIV-1, HXB-2D. The PLAP gene
encodes a cell surface, glycosylphosphatidylinositol-anchored
protein that is not normally present on cells of the lymphoid
lineage. The PLAP gene product can be easily stained by
indirect immunofluorescence to allow quantitative detection
by flow cytometry. Furthermore, because glycosylphosphatidy-
linositol-anchored proteins generally have a low turnover rate
(37), accumulation of PLAP may also serve as an indicator of
the stage of virus infection and efficiency of virus gene expres-
sion.
As a preliminary test of the system, we examined whether
PLAP itself may affect levels of cell surface CD4 or whether it
might have toxic effects upon cell growth outside the context of
HIV infection. We infected Jurkat cells with amphotropic-
enveloped, helper-free MLV expressing the PLAP gene. In a
population of Jurkat cells infected with this nonreplicating
vector, levels of PLAP detected on PLAP-positive cells did not
change appreciably over 28 days of propagation, suggesting
that the expression of PLAP has little or no detrimental effect
upon the growth of Jurkat T cells (Fig. 1A). High-level PLAP
expression was maintained for over one month in a fixed per-
centage of cells in the absence of selection (Fig. 1B). The
percentage of PLAP-positive cells remained stable in both the
CD41 and CD42 compartments. Fluorescence intensity values
for CD4 and PLAP in these cells did not vary appreciably over
this period, demonstrating that the expression of PLAP itself
does not affect the levels of cell surface CD4 (data not shown).
Placement of the PLAP gene in two distinct coding regions
of the HIV genome allowed us to selectively mark cells from
the early or late stages of virus infection (Fig. 2). The resulting
viruses, HXBnPLAP or HXBePLAP, do not express nef or env,
respectively, but instead produce PLAP in place of one of
these gene products. Replacing nef with PLAP in HXBnPLAP
produced a replication-competent HIV strain that expressed
PLAP with early gene kinetics. Replacement of the env gene
with PLAP in HXBePLAP produced a virus which expressed
PLAP with late gene kinetics. Infection with HXBePLAP re-
quired trans complementation of the missing env gene during
virus production. This could be accomplished efficiently by
cotransfecting 293 cells with an expression vector for the MLV
amphotropic envelope with the env-deficient proviral DNA to
give rise to a pseudotyped HIV [HXBePLAP(ampho)] com-
petent for a single round of infection (7, 20, 22).
Infection in the absence of vpu, env, and nef. We first ana-
lyzed the effects of infection of the CD41 Jurkat T-cell line
with a viral construct which expressed none of the genes im-
plicated in CD4 regulation (Fig. 3A). The virus, HXBePLAP
N2(ampho), expressed PLAP in place of env and contained a
frameshift mutation in the nef reading frame. In addition, the
HXB-2D molecular clone contains a point mutation in the
initiation codon of vpu which abrogates expression of this
gene. Western blot analysis showed that HXBePLAP N2 did
not express Vpu, Env, or Nef (Fig. 4, lane 1). Infection with
HXBePLAP N2(ampho) gave rise to a population of cells that
stained positive for PLAP and could be monitored over time by
flow cytometry. Examination of the infection on day 3, at a
time when near-maximal numbers of PLAP1 cells were de-
tected, revealed no apparent changes in the level of CD4 ex-
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pression on PLAP1 cells compared with PLAP2 cells (Fig.
5B). After day 3, the percentage of PLAP1 cells decreased
over time (data not shown), suggesting that in the absence of
new rounds of viral infection, infected cells were at a compet-
itive disadvantage with respect to uninfected cells. Small num-
bers of CD42 cells were found to be PLAP1. These PLAP1
CD42 cells were probably due to the infection of CD42 Jurkat
cells by amphotropic envelope-pseudotyped HIV because the
small fraction of CD42 cells in the PLAP1 population re-
flected the fraction of CD42 cells normally found in Jurkat
cells. As a comparison, mock-infected Jurkat cells were largely
CD4 positive with only minimal background PLAP staining
(Fig. 5A). This result demonstrates that inactivation of nef,
vpu, and env is sufficient to eliminate all CD4-modulatory func-
tion during viral infection.
Effect of nef alone on CD4 down-modulation. We next de-
termined the effect on CD4 of a virus expressing nef as the sole
potential CD4-modulatory factor, HXBePLAP (Fig. 3A shows
the structure and genotype). In contrast to HXBePLAP N2,
HXBePLAP produced a functional Nef (Fig. 4, lane 2). When
infected with HXBePLAP(ampho), virtually all cells express-
ing PLAP were CD4 negative (Fig. 5C), in contrast to infection
with HXBePLAP N2 (Fig. 5B). In the infection with HXBe
PLAP(ampho), PLAP is predicted to be expressed with late-
gene kinetics and consequently marks only those cells in the
late phase of HIV infection. The nearly complete absence of
PLAP1 CD41 cells in this infection suggests that all PLAP1
cells had produced sufficient quantities of the early protein,
Nef, to down-modulate most of their cell surface CD4 before
the expression of significant levels of surface PLAP. This result
suggests that nef has a strong down-modulatory effect on sur-
face CD4 which is evident before the expression of late genes
such as env.
Effect of env alone on CD4 down-modulation. We next con-
structed and examined a virus expressing env but not vpu or
nef, designated HXBnPLAP (Fig. 3B shows the structure and
genotype; Fig. 4, lane 3, shows the Western blot). When in-
fected with HXBnPLAP, Jurkat cells with low levels of PLAP
(1- to 50-fold above background staining [PLAPlo]) maintained
high levels of CD4 (Fig. 5D). However, cells expressing the
higher levels of PLAP (greater than 50-fold over background
[PLAPhi]) down-regulated CD4 to a level close to that on cells
expressing no CD4. This virus expresses PLAP with early-gene
kinetics, so that the protein may accumulate on the cell surface
during both the early and late stages of infection. Unlike
HXBePLAP, HXBnPLAP is replication competent and in 7 to
10 days can spread to infect the majority of cells in a culture
(data not shown). At such late times in infection, virtually all
FIG. 1. Stable expression of PLAP in Jurkat cells by helper-free MLV infection. Jurkat cells were infected with an amphotropic-enveloped, replication-deficient
MLV vector expressing PLAP, DAP(ampho). (A) Flow-cytometric analysis of infected cells stained for CD4 and PLAP 3 and 28 days after infection. (B) Graph
illustrating the percentage of cells in the infected culture staining positive for PLAP over time, as determined by FACSCAN analysis.
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cells eventually progress to become PLAPhi, suggesting that
levels of PLAP allow the discrimination between early events
in PLAPlo cells and late events in PLAPhi cells. The observa-
tion that only PLAPhi cells have down-modulated CD4 dem-
onstrates that env can independently and efficiently down-mod-
ulate CD4 in Jurkat cells in the late phase of the HIV life cycle.
Effect of vpu alone on CD4 down-modulation. To test
whether viruses expressing vpu in the absence of nef and env
could also down-modulate CD4, we restored the vpu reading
frame by repairing the vpu translation initiation codon of
HXB-2D in the virus HXBnPLAP. When the ATG was re-
paired, the Vpu protein could be readily detected by Western
blotting of cells transfected with the proviral DNA (Fig. 4, lane
4). So that we might observe the effects of vpu on CD4 without
the coexpression of env, we inactivated the envelope reading
frame by introducing a frameshift near the 59 end of the env
gene. This env-deficient, nef-deficient virus, HXBnPLAP
U1E2 (Fig. 3B shows the structure and genotype) was nonin-
fectious unless pseudotyped with MLV amphotropic envelope
(data not shown). When pseudotyped, the resulting virus,
HXBnPLAP U1E2(ampho), was competent for only a single
round of infection. A virus expressing vpu but not env or nef
could induce significant CD4 down-modulation in PLAPhi cells
(Fig. 5E), demonstrating that like env, vpu can independently
regulate CD4 late during infection. In addition, a chimeric
HXB-2D-based virus with an identical CD4 modulatory geno-
type (U1E2N2) containing the vpu and env sequence from
another molecular clone of HIV-1, NL4-3, was made. This
virus produced an identical CD4 modulation phenotype to that
of HXBnPLAP U1E2 (data not shown), confirming that this
effect could be observed with two different alleles of vpu.
Effect of combinations of CD4 modulatory genes. To evalu-
ate how different combinations of the CD4-modulatory genes
cooperate in their effects on CD4, we first analyzed the com-
bination of env and vpu expression during virus infection of
Jurkat cells. The virus HXBnPLAP U1 expresses PLAP with
early-gene kinetics in addition to both env and vpu (Fig. 3B
shows the genotype; Fig. 4, lane 5, shows the Western blot).
This virus induced PLAPhi cells to down-modulate CD4 simi-
larly to virus which expressed either env or vpu alone (Fig. 5F;
compare with Fig. 5D and E). The levels of CD4 down-mod-
ulation were subtly but reproducibly more efficient with the
combination of the two than with either gene alone (see the
quantitative analysis described below).
We next designed a virus capable of expressing PLAP along
with all three CD4-regulatory genes. To accomplish this, we
introduced an IRES from encephalomyocarditis virus (11, 28)
into the region immediately upstream of the nef gene in the
HXBnPLAP virus. When inserted into an RNA molecule, this
picornavirus element allows for cap-independent initiation of
translation at a downstream AUG (24). We simultaneously
repaired the nef reading frame so that full-length Nef could be
translated under the control of the IRES. The resulting virus,
HXBnPLAP IRES-N1 (Fig. 3C shows the structure and geno-
type), should produce Nef from the early stage of the virus life
cycle. Western blot analysis showed that Nef protein was
present at high levels in 293 cells transfected with HXBnPLAP
IRES-N1 (Fig. 4).
When Nef was produced in addition to Env during viral
infection by HXBnPLAP IRES-N1, a larger fraction of PLAP-
positive cells was CD4 negative, as a result of an increase in the
numbers of PLAPlo cells with decreased levels of CD4 (Fig.
5G; compare with Fig. 5D). This finding suggests that during
infection by a nef1 virus, CD4 down-modulation occurs effi-
ciently in the early phase of the virus life cycle, when Nef is
expressed.
FIG. 2. Genomic organization and pattern of mRNA splicing of recombinant HIV constructs made to express PLAP. Parental virus, HXB-2D, is shown at the top,
and the insertion of PLAP into the nef and env reading frames is illustrated below the sequence. HXBnPLAP contains an inserted PLAP gene at the 59 end of nef. PLAP
is expressed with early-gene kinetics on a multiply spliced mRNA. HXBePLAP contains an inserted PLAP gene at the 59 end of env. PLAP is expressed with late-gene
kinetics on a singly spliced mRNA. Genes that are shaded indicate open reading frames expressed in the virus construct. Unshaded genes are not expressed by that virus.
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Infection of Jurkat cells with virus containing all three reg-
ulatory genes, HXBnPLAP U1-IRES N1 (Fig. 3C shows the
structure and genotype) displayed a pattern generally similar
to that with a virus carrying nef and env (Fig. 5H). A quanti-
tative analysis described below demonstrates that the addition
of vpu to a virus carrying env and nef did induce an additional
decrease in the levels of CD4. As a control to determine
whether the insertion of an IRES may alter the intrinsic CD4-
modulatory effects of a virus, we compared a virus which con-
tained an IRES element with one with the same CD4-modu-
latory genotype without an IRES. A disruption of the nef open
reading frame in HXBnPLAP IRES-N1 by a frameshift mu-
tation creates the virus HXBnPLAP-IRES N2 (U1E1N2),
which has the same CD4-modulatory genotype as HXBnPLAP
U1 (also U1E1N2 [Fig. 3C]). When these viruses were used
to infect Jurkat cells, the addition of an IRES did not alter the
pattern of CD4 down-modulation (Fig. 5I; compare Fig. 5F).
Infection of primary cells and comparison with Jurkat cells.
Infection of PBMC with PLAP-expressing HIV gave rise to a
percentage of PLAP1 cells similar to that seen with Jurkat
cells. As in Jurkat cells, in the absence of all three CD4-
modulatory genes, the virus had no effect upon cell surface
CD4 (Fig. 6B). When viruses carrying nef, env, and vpu genes
individually were used to infect PBMC, they again showed
independent CD4 down-modulatory effects (Fig. 6C through
E). The extent to which each of these genes acted in primary
cells, however, was significantly weaker. In particular, CD4
down-modulation with env or with vpu as the sole CD4-mod-
ulatory factor was less efficient in PBMC than in Jurkat cells.
For example, a smaller fraction of total PLAPhi cells had
down-modulated CD4 when PBMC were infected with a virus
expressing env alone, HXBnPLAP, compared with that in a
similar analysis with Jurkat cells (compare Fig. 6D with Fig.
5D). While infection with HXBnPLAP down-modulated CD4
in more than 65% of PLAPhi Jurkat cells at 3 days postinfec-
tion, only 20% of such a population down-modulated CD4 in
FIG. 3. Genomic organization and CD4-modulatory genotype of HIV constructs fall into three major subtypes: vectors expressing PLAP in place of env, designated
HXBePLAP (A); vectors expressing PLAP in place of nef, designated HXBnPLAP (B); and vectors expressing PLAP in place of nef with a restored nef open reading
frame driven by an IRES, designated HXBnPLAP IRES (C). All virus constructs are identical in the 59 half to the left of the parallel slash marks. Viral genes that are
shaded indicate open reading frames expressed in the virus construct. Unshaded genes are not expressed by that virus. The code for CD4-modulatory genes is as follows:
U, vpu; E, env; N, nef.
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PBMC (Table 1). A similar phenomenon was evident when
PBMC were infected with a virus which expresses vpu alone
(HXBnPLAP U1E2). This case illustrated that the down-
modulation function of vpu is less efficient in PBMC than in
Jurkat cells (compare Fig. 6E with Fig. 5E). Interestingly, vpu
alone performed slightly better in PBMC than did env alone,
whereas the reverse occurred in Jurkat cells (Table 1).
Because the down-modulation was less efficient by env or
vpu alone in PBMC, the overall importance of nef in CD4
modulation is greater in PBMC than in Jurkat cells. In partic-
ular, a greater fraction of maximal CD4 down-modulation can
be attributed to Nef function in PBMC. On day 3 of an infec-
tion, only in the presence of nef did down-modulation of CD4
increase to above 33% of primary cells, whereas in Jurkat cells,
over 75% of the cells had low CD4 levels when infected with a
virus expressing both env and vpu but not nef (Table 1).
Quantitative analysis of CD4 down-modulation. When we
compared the average levels of CD4 fluorescence on cells
which had achieved equivalent levels of PLAP fluorescence,
more subtle differences in the efficiency of CD4 modulation
were appreciated (Fig. 7). In Jurkat cells, vpu alone was less
efficient than env alone in down-modulating CD4. The combi-
nation of the two genes was more efficient than was either one
alone. In contrast, vpu alone was more efficient than env alone
in PBMC, and the combination of the two late genes was only
slightly better at down-regulating CD4 than was vpu alone. As
discussed above, we observed a greater dependence on nef to
achieve maximal CD4 down-modulation in PBMC. In both cell
types, the lowest CD4 staining was observed after infection
with virus that expresses all three regulatory genes.
The level of CD4 staining in Jurkat cells infected with a virus
containing all three gene products was nearly equivalent to the
intensity of staining found on a control sample stained with an
isotype-matched monoclonal antibody, suggesting that deple-
tion of CD4 in this case is nearly complete. We estimate that
on average, 98% of the total CD4-associated fluorescence is
removed from infected, PLAPhi cells. During the infection of
PBMC, the efficiency of down-modulation at a similar 3-day
time point was impressive but not as great as that seen in
Jurkat cells. We found that on average, 92% of the original
levels of CD4-associated fluorescence was removed from the
surface of PLAPhi PBMC. While the average percentage of
CD4 removed from the surface of Jurkat cells was greater than
that removed from PBMC, it is important to consider that
primary CD41 T cells have three- to fourfold-higher levels of
CD4-associated fluorescence (Fig. 7). This observation sug-
gests that the total amount of CD4 down-modulated from each
T cell is potentially greater in PBMC.
DISCUSSION
We have used a sensitive, virus-based marker gene system to
quantitatively determine the relative contributions of vpu, env,
and nef to the regulation of the viral receptor, CD4, during the
infection of both a T-cell line and primary CD41 T cells. We
show that in the absence of these viral genes, no down-modu-
lation of cell surface CD4 takes place during infection. We
found that each of these three genes is capable of mediating
CD4 down-modulation independently but with differing final
efficiencies in T-cell lines versus primary T cells.
We demonstrate the cooperative effects of vpu, env, and nef
on CD4 levels during infection of primary human CD41 cells.
While all three genes are able to down-modulate CD4 inde-
pendently, combinations of them are able to do so faster and
more completely. Only when all three genes are expressed do
we see maximal CD4 down-modulation in Jurkat cells or
PBMC. The cooperative effects of these CD4 regulatory genes
appear to be even more critical in primary cells, in which CD4
modulation is less efficient, perhaps as a result of higher initial
levels of cell surface CD4 in primary T cells. We found that in
PBMC, nef seems to account for a larger fraction of the total
CD4 down-modulating activity than in the Jurkat cell line.
Interestingly, nef is the only HIV gene which is thought to
down-regulate CD4 molecules that are present on the cell
surface before an infection. A heavy reliance on nef in these
cells might suggest that primary cells have a lower intrinsic
turnover rate of CD4 than do Jurkat cells.
Substantial evidence indicates that nef and env, when over-
expressed in CD41 cells on their own, can down-modulate
CD4. A previous study has suggested that the levels of trans-
fected Nef expressed in cells may be important in determining
whether nef can down-modulate CD4 (31). Our data support
evidence that nef decreases CD4 levels during virus infection of
transformed T cells (1) and further establish that these func-
tions are temporally regulated, with nef functioning early and
env and vpu functioning late in the viral life cycle during the
infection of both Jurkat cells and primary human CD41 lym-
phocytes.
Previous metabolic labelling studies which determined the
half-life of CD4 in transfected HeLa cells predicted that the
CD4-modulatory function of vpu may be dependent upon env
(41). Another study of transfected HeLa cells demonstrated
that expression of large amounts of Vpu relative to CD4 could
result in decreased levels of CD4 in the absence of other viral
genes products including Env (19). Our data show that env is
not essential for the CD4-modulatory function of vpu during
FIG. 4. Western blot analyses of 293 cells transfected with proviral DNAs to
produce PLAP viruses. Blots were developed with anti-vpu (A), anti-env (B),
anti-nef (C), and anti-HIV (D) antisera. The anti-HIV blot serves as a control for
the amount of total viral proteins produced in these total-cell lysates.
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FIG. 5. Flow-cytometric analysis of Jurkat cells infected with different viral constructs analyzed 3 days after infection. Analysis of other time points, both earlier and
later, showed similar trends of PLAP and CD4 staining (data not shown). Data from day 3 are illustrated because they show the maximum number of PLAP1 cells
for env2 constructs, which generally begins to decrease after this time point. Contour plots of infected cells are presented in a logarithmic scale to clearly illustrate
relatively low-frequency events. (A) Uninfected Jurkat cells; (B through I) infections of Jurkat cells by HIV constructs with the indicated genotype. All samples shown
are stained by indirect immunofluorescence with antibodies against CD4 and PLAP. The single-letter code U (vpu), E (env), and N (nef) represents the CD4-modulatory
genotype of the virus used in each experiment.
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FIG. 6. Flow-cytometric analysis of PBMC infected with different viral constructs analyzed 3 days after infection. Analysis of other time points, both earlier and later,
showed similar trends of PLAP and CD4 staining (data not shown). Data from day 3 are illustrated because they show the maximum number of PLAP1 cells for env2
constructs, which generally begins to decrease after this time point. Contour plots of infected cells are presented in a logarithmic scale to clearly illustrate relatively
low-frequency events. (A) Uninfected PBMC; (B through I) infections of PBMC by HIV constructs with the indicated genotype. All samples shown are stained by
indirect immunofluorescence with antibodies against CD4 and PLAP. The single-letter code U (vpu), E (env), and N (nef) represents the CD4-modulatory genotype
of the virus used in each experiment.
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infection of human T cells, indicating that the levels of Vpu
produced during infection are sufficient to influence endoge-
nous levels of cell surface CD4. While the CD4-modulatory
function of vpu is not dependent upon the expression of env, it
is still likely that the ability of Env to reach the cell surface will
depend upon the ability of Vpu to degrade nascent CD4 mol-
ecules and thereby inhibit the formation of CD4-gp160 aggre-
gates.
These studies make it clear that HIV has evolved three
independent mechanisms to ensure that CD4 levels in infected
cells are efficiently reduced. When working together, these
three viral genes achieve what we estimate is virtually complete
depletion of cell surface CD4. This focus on CD4 regulation
implies that the down-modulation of CD4 should be critical for
the optimal fitness or perhaps the survival of the virus in vivo.
Despite this presumed importance, the true function of this
phenomenon remains speculative. It is possible that CD4
down-modulation enhances the fitness of newly emerging vi-
ruses. For example, receptor down-modulation may be impor-
tant in enhancing virus particle release or preventing receptor
incorporation into particles, which could result in aggregation
of virions or functional inactivation of the viral envelope.
These mechanisms have precedent in other viral systems, e.g.,
influenza virus, in which inactivation of the viral receptor by
neuraminidase is critical for release of infectious virus particles
(21, 33). Because the CD4 molecule is involved in T-cell signal
transduction, down-modulation may have functional sequelae
in the infected T cell. It has been suggested that down-modu-
lation of CD4 may cause the release of the Src-like tyrosine
kinase, Lck, which normally associates with the cytoplasmic tail
of CD4 (1). Release of this molecule could lead to T-cell
activation, which in turn might improve the cellular environ-
ment for viral replication. Another hypothesis suggests that
receptor down-modulation could protect an infected cell from
a CD4-mediated pathway toward apoptosis (2). Lastly, it has
been suggested that CD4 down-modulation is a mechanism
which the virus uses to avoid superinfection toxicity (3). These
hypotheses are by no means inconsistent with one another;
therefore, further studies must be done to test the validity of
any one.
In apparent contradiction to in vitro studies, DNA PCR
analysis on PBMC from HIV-infected patients finds that most
proviral DNA is associated with CD41 cells (30). The reasons
for this discrepancy are unclear; however, several explanations
are possible. Recent studies have estimated that productively
infected T lymphocytes survive only 2 days following infection
in vivo (14, 38). The inability to find proviral DNA in CD42
cells may be a result of the short average lifetime of a produc-
tively infected cell. In contrast, cells infected with defective or
nonproductive virus are likely to be more long-lived. Thus,
DNA PCR of peripheral blood cells may provide a biased
measure mainly of cells which have been infected with defec-
tive or nonproductive virus and, consequently, would maintain
high levels of CD4. If the short half-life of infected cells is due
largely to the effects of a highly efficient cytotoxic T-cell re-
sponse, one would predict that CD42 HIV1 cells could be
detected at a higher frequency during acute infection before a
specific anti-HIV response has developed. Such a hypothesis
has yet to be tested.
FIG. 7. Average CD4-associated fluorescence intensity of PLAPhi cells for
cells infected with the designated viruses. PLAPhi cells are those that stain
greater than 50-fold over background levels by flow cytometry and can be found
within region R1 or R2, as illustrated in Fig. 5H and 6H. All cells which fall into
either of these regions were included in this analysis. The isotype control analysis
shown was performed with an anti-trinitrophenol mouse immunoglobulin G2a
antibody to determine background fluorescence levels.
TABLE 1. CD4 down-modulation ratio on day 3 of infectiona
Virus Genotype
Jurkat PBMC
% CD4lo % CD4hi Down-Mod ratio % CD4lo % CD4hi Down-Mod ratio
HXBePLAP N2 U2E2N2 0 100 0.00 10 90 0.11
HXBePLAP U2E2N1 97 3 36.00 90 10 9.43
HXBnPLAP U2E1N2 67 33 2.00 20 80 0.25
HXBnPLAP U1E2 U1E2N2 41 59 0.68 25 75 0.33
HXBnPLAP U1 U1E1N2 77 23 3.42 33 67 0.48
HXBnPLAP IRES-N1 U2E1N1 98 2 40.25 91 9 9.71
HXBnPLAP U1IRES-N1 U1E1N1 100 0 .53 91 9 9.84
HXBnPLAP U1IRES-N2 U1E1N2 71 29 2.50 21 79 0.27
a See flow cytometry plots in Fig. 5H and 6H for definition of region 1 (R1) and region 2 (R2) for Jurkat cells and PBMC, respectively. [R2/(R1 1 R2)] 3 100%
5 %CD4lo, representing the percentage of all PLAPhi cells which have down-modulated CD4. [R1/(R1 1 R2)] 3 100% 5 %CD4hi, representing the percentage of
all PLAPhi cells which have not down-modulated CD4. %CD4lo/%CD4hi 5 down-modulation (Down-Mod) ratio.
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An alternative explanation of why CD42 HIV1 cells have
not been found in patients is that CD4 down-modulation may
be evident only during active infection of T cells in the periph-
eral lymphoid organs. Productively infected cells may prefer-
entially home to lymphoid organs following cellular and viral
activation. Since HIV does not replicate in the quiescent T
cells and since the T cells found circulating in the peripheral
blood are not normally in an activated state, perhaps the bulk
of productive infection and consequent CD4 down-modulation
are evident primarily in the peripheral lymphoid organs. This
hypothesis would predict that CD42 HIV1 cells may be found
in lymph nodes. Future studies on viral regulation of CD4
should be directed toward understanding the functional con-
sequences of CD4 down-modulation for the virus and T cells
and understanding how this process may be important in the
pathogenesis of AIDS.
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